Pasithea Therapeutics (KTTA) Stock Price & Financial Analysis
Pasithea Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Pasithea Therapeutics
What is the current stock price for KTTA?
As of the latest trading session, KTTA stock trades at $0.70. The 52-week range is $0.28–$2.06, with a day range of $0.68–$0.77.
What is the P/E ratio for KTTA?
The P/E ratio (Price-to-Earnings) for KTTA is shown in the Key Statistics section. This valuation metric helps compare Pasithea Therapeutics Corp. to industry peers.
Does KTTA pay dividends?
Pasithea Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for KTTA?
Based on 1 analyst, the consensus for KTTA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of KTTA?
Pasithea Therapeutics's market capitalization is $4.9M, classifying it as a micro-cap company. Pasithea Therapeutics operates in the Healthcare sector within the Biotechnology industry.